Skip to main content
. 2024 Sep 24;98(10):e00689-24. doi: 10.1128/jvi.00689-24

TABLE 1.

Description and demographics for participants selected for this study

Study group Sex Age (years) Baseline
HAI titer
# with Day 0 and Day 30 # with
Day 182
Vaccine received in
2020–2021
Vaccine received in
2021–2022
1xVax Male 24–44 5 8 6 Placebo FluBlok
Female 20–29 5 7 4 Placebo FluBlok
2xVax Male 23–45 5 8 8 FluBlok FluBlok
Female 25–43 5 7 3 FluBlok FluBlok